3srg
From Proteopedia
(Difference between revisions)
(4 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
+ | |||
==Serum paraoxonase-1 by directed evolution at pH 6.5 in complex with 2-hydroxyquinoline== | ==Serum paraoxonase-1 by directed evolution at pH 6.5 in complex with 2-hydroxyquinoline== | ||
- | <StructureSection load='3srg' size='340' side='right' caption='[[3srg]], [[Resolution|resolution]] 2.19Å' scene=''> | + | <StructureSection load='3srg' size='340' side='right'caption='[[3srg]], [[Resolution|resolution]] 2.19Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[3srg]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[3srg]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3SRG OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3SRG FirstGlance]. <br> |
- | </td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BR:BROMIDE+ION'>BR</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=LMT:DODECYL-BETA-D-MALTOSIDE'>LMT</scene>, <scene name='pdbligand=OCH:QUINOLIN-2(1H)-ONE'>OCH</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.19Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BR:BROMIDE+ION'>BR</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=LMT:DODECYL-BETA-D-MALTOSIDE'>LMT</scene>, <scene name='pdbligand=OCH:QUINOLIN-2(1H)-ONE'>OCH</scene></td></tr> | |
- | <tr | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3srg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3srg OCA], [https://pdbe.org/3srg PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3srg RCSB], [https://www.ebi.ac.uk/pdbsum/3srg PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3srg ProSAT]</span></td></tr> |
- | + | </table> | |
- | <table> | + | |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 14: | Line 14: | ||
Catalytic Versatility and Backups in Enzyme Active Sites: The Case of Serum Paraoxonase 1.,Ben-David M, Elias M, Filippi JJ, Dunach E, Silman I, Sussman JL, Tawfik DS J Mol Biol. 2012 Mar 1. PMID:22387469<ref>PMID:22387469</ref> | Catalytic Versatility and Backups in Enzyme Active Sites: The Case of Serum Paraoxonase 1.,Ben-David M, Elias M, Filippi JJ, Dunach E, Silman I, Sussman JL, Tawfik DS J Mol Biol. 2012 Mar 1. PMID:22387469<ref>PMID:22387469</ref> | ||
- | From | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> |
</div> | </div> | ||
+ | <div class="pdbe-citations 3srg" style="background-color:#fffaf0;"></div> | ||
==See Also== | ==See Also== | ||
- | *[[Journal:JMB:3|Journal:JMB:3]] | ||
*[[Serum Paraoxonase|Serum Paraoxonase]] | *[[Serum Paraoxonase|Serum Paraoxonase]] | ||
== References == | == References == | ||
Line 24: | Line 24: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Large Structures]] |
[[Category: Synthetic construct]] | [[Category: Synthetic construct]] | ||
- | [[Category: David | + | [[Category: Ben David M]] |
- | [[Category: Elias | + | [[Category: Elias M]] |
- | [[Category: Silman | + | [[Category: Silman I]] |
- | [[Category: Sussman | + | [[Category: Sussman JL]] |
- | [[Category: Tawfik | + | [[Category: Tawfik DS]] |
- | + | ||
- | + | ||
- | + |
Current revision
Serum paraoxonase-1 by directed evolution at pH 6.5 in complex with 2-hydroxyquinoline
|